Douglas Mullen is the Entrepreneur in Residence at the Michigan Nanotechnology Institute for Medicine and Biological Sciences where he is focused on accelerating the commercialization of technology developed by the Institute. Doug joined MNIMBS after completing his tenure as the Dick Sarns Medical Innovation Fellow at the University of Michigan Medical Innovation Center (MIC). As a member of a multi-disciplinary fellowship team at the MIC, Doug identified unmet needs and opportunities in the health system through an intensive clinical immersion program. He was instrumental in designing and developing an emergency intubation device that addresses one of the major healthcare challenges identified through the MIC’s process. To continue development of the device, he co-founded a medical device start-up company called Brio Device.
Prior to his fellowship, Doug earned his PhD in Macromolecular Science and Engineering from the University of Michigan in 2010, having worked as a member of MNIMBS and the Banaszak Holl research group. His thesis work focused on the design and development of targeted nanotheraputic agents for cancer and rheumatoid arthritis. As a graduate student, Doug contributed to over 17 peer-reviewed articles in the fields of nanomedicine and engineering. While in graduate school, Doug participated in the MBA Essentials and Entrepreneurship Program at the Ross School of Business and was a member of the Frankel Commercialization Fund’s Healthcare Team focusing on pre-seed investments in early stage healthcare companies. In addition to a PhD, Doug holds a MSE in Macromolecular Science and Engineering and a Certificate of Graduate Studies in Nanoscience and Technology from the University of Michigan as well as a BSE in Mechanical Engineering from Duke University.